Evidence map›Paper›PMID 34876836›Full record

ArticleInternational journal of general medicine2021

Preliminary Study on the Relationship of

Linjue Shangguan, Peipei Zhang, Shengwei Fang, Kaili Xiang, Yawen Geng, Dingcun Luo, Chunlei Zhao

Abstract read
In one paragraph

Article in International journal of general medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Linjue Shangguan *Department of Nuclear Medicine, Hangzhou Cancer Hospital, Hangzhou, 310002, People's Republic of China.ORCID 0000-0002-5347-917X
Peipei ZhangDepartment of Nuclear Medicine, Hangzhou Cancer Hospital, Hangzhou, 310002, People's Republic of China.
Shengwei FangDepartment of Nuclear Medicine, Hangzhou Cancer Hospital, Hangzhou, 310002, People's Republic of China.
Kaili XiangDepartment of Nuclear Medicine, Hangzhou Cancer Hospital, Hangzhou, 310002, People's Republic of China.
Yawen GengDepartment of Nuclear Medicine, Hangzhou Cancer Hospital, Hangzhou, 310002, People's Republic of China.
Dingcun Luo *Department of Tumor Surgery, Hangzhou First People's Hospital, Hangzhou, 310006, People's Republic of China.ORCID 0000-0002-8384-5054
Chunlei Zhao *Department of Nuclear Medicine, Hangzhou Cancer Hospital, Hangzhou, 310002, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the relationship of

methodsThirty-three patients with PTC who underwent their first

results

conclusionThe value of

Indexed as

BRAFgene mutationpapillary thyroid carcinomaradiotherapy

Identifiers

PMID34876836
PMCPMC8643224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.